Placental Growth and Adverse Pregnancy Outcomes

Completed

Conditions studied: Hypertension Induced by Pregnancy, Pre-Eclampsia, IUGR

In brief

The purpose of this study to determine if measurement of maternal serum biomarkers and evaluation of the placenta by ultrasound can improve prediction of adverse pregnancy outcomes.

Key facts

Study ID

NCT01669525

Run by

University of Pennsylvania

People needed

1043

Starts

2009-11-01

Expected to finish

2016-06-01

Last updated by the study team

2017-07-18

Who can join

Age: any. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• All singleton gestations presenting for Sequential Screen testing at HUP
• patients competent to provide verbal informed consent

You may not qualify if…

• Multiple gestations
• patients not competent to provide informed consent
• patients found to be too late for the Sequential Screen
• pregnancy losses 20 weeks gestation
• major fetal anomalies
• patient delivering outside of the UPHS

Where it is running

• University of Pennsylvania Health System — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.